ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · Real-Time Price · USD
60.65
+0.49 (0.81%)
May 20, 2025, 4:00 PM - Market closed
ANI Pharmaceuticals Market Cap
ANI Pharmaceuticals has a market cap or net worth of $1.21 billion as of May 21, 2025. Its market cap has decreased by -14.18% in one year.
Market Cap
1.21B
Enterprise Value
1.69B
1-Year Change
-14.18%
Ranking
Category
Stock Price
$60.65
Market Cap Chart
Since May 5, 2000, ANI Pharmaceuticals's market cap has increased from $31.10M to $1.21B, an increase of 3,803.65%. That is a compound annual growth rate of 15.75%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 19, 2025 | 1.30B | 12.10% |
Dec 31, 2024 | 1.16B | 3.16% |
Dec 29, 2023 | 1.13B | 60.39% |
Dec 30, 2022 | 702.60M | 19.57% |
Dec 31, 2021 | 587.60M | 63.72% |
Dec 31, 2020 | 358.90M | -51.87% |
Dec 31, 2019 | 745.70M | 39.70% |
Dec 31, 2018 | 533.80M | -28.93% |
Dec 29, 2017 | 751.10M | 6.89% |
Dec 30, 2016 | 702.70M | 35.42% |
Dec 31, 2015 | 518.90M | -18.78% |
Dec 31, 2014 | 638.90M | 235.20% |
Dec 31, 2013 | 190.60M | 533.22% |
Dec 31, 2012 | 30.10M | -45.47% |
Dec 30, 2011 | 55.20M | -52.74% |
Dec 31, 2010 | 116.80M | 50.13% |
Dec 31, 2009 | 77.80M | 183.94% |
Dec 31, 2008 | 27.40M | -73.32% |
Dec 31, 2007 | 102.70M | 58.73% |
Dec 29, 2006 | 64.70M | -8.62% |
Dec 30, 2005 | 70.80M | -29.83% |
Dec 31, 2004 | 100.90M | 79.86% |
Dec 31, 2003 | 56.10M | 95.47% |
Dec 31, 2002 | 28.70M | -46.55% |
Dec 31, 2001 | 53.70M | 72.12% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 679.94B |
Johnson & Johnson | 364.11B |
AbbVie | 325.05B |
Novo Nordisk | 282.81B |
UnitedHealth Group | 264.80B |
Abbott Laboratories | 234.53B |
Novartis AG | 213.43B |
AstraZeneca | 212.39B |